Henry Schein Inc. secured the rights to distribute Jaguar Animal Health Inc.'s Neonorm foal product in the U.S. equine market.

Henry Schein will be responsible for obtaining regulatory approvals to market and distribute the anti-diarrheal product for foals.

The agreement will run for an initial one-year period that started Dec. 9; it will renew automatically unless canceled.